Nerve Conduction Studies and Electromyography
J9 · Effective Oct 1, 2015
15 active Medicare policies list N36.44, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Oct 1, 2025
J9 · Effective Oct 1, 2025
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of N36.44 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
J5 · Effective Mar 5, 2026
National · Effective Apr 6, 2026
National · Effective Mar 5, 2026
National · Effective Oct 2, 2025
J6 · Effective Apr 1, 2026